Applied Therapeutics, Inc.
APLT
$0.441
-$0.0191-4.15%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -15.28% | -24.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -15.28% | -24.21% | |||
| Cost of Revenue | 48.22% | -18.11% | |||
| Gross Profit | -49.15% | 18.02% | |||
| SG&A Expenses | 42.13% | 16.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 45.09% | -3.28% | |||
| Operating Income | -45.51% | 3.10% | |||
| Income Before Tax | -2,466.84% | 103.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2,466.84% | 103.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2,466.84% | 103.45% | |||
| EBIT | -45.51% | 3.10% | |||
| EBITDA | -45.51% | 3.09% | |||
| EPS Basic | -2,464.18% | 103.00% | |||
| Normalized Basic EPS | -2,437.80% | 103.03% | |||
| EPS Diluted | -264.98% | 80.57% | |||
| Normalized Diluted EPS | -2,574.17% | 102.87% | |||
| Average Basic Shares Outstanding | 0.29% | 14.85% | |||
| Average Diluted Shares Outstanding | -5.28% | 21.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
